Helga B. Salvesen

Bergen, 5020, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications
Published: September 09, 2025

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.

Journal: Nature communications
Published: December 03, 2021

Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma.

Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: November 26, 2019

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.

Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.

Journal: Scientific reports
Published: August 03, 2018

Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.

Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.

Journal: PloS one
Published: June 05, 2018

The genetic landscape of 87 ovarian germ cell tumors.

The genetic landscape of 87 ovarian germ cell tumors.

Journal: Gynecologic oncology
Published: June 04, 2018

PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.

PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 16, 2018

White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.

White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.

Journal: Annals of internal medicine
Published: January 17, 2018

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 12, 2018

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2017

Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.

Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.

Journal: Gynecologic oncology
Published: September 29, 2017

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Journal: British journal of cancer
Published: August 08, 2017
Showing 1-12 of 148

Last Updated: 09/26/2026